Skip to main content
SpringerLink
Log in

Neue Ära der zielgerichteten Therapie

Inhibition von RET-Alterationen beim Schilddrüsenkarzinom und NSCLC

  • Allgemeine Onkologie
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Author information

Authors and Affiliations

  1. Freie Medizinjournalistin, Dresden, Deutschland

    Sabrina Kempe

Authors
  1. Sabrina Kempe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabrina Kempe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kempe, S. Inhibition von RET-Alterationen beim Schilddrüsenkarzinom und NSCLC. Im Fokus Onkologie 25, 50–52 (2022). https://doi.org/10.1007/s15015-022-3796-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-022-3796-0

Search

Navigation